EIN News: China, Taiwan & Hong Kong Biotechnology & GMOs News

Novel Drug Delivery Mechanisms Offer Significant Potential for the European Pharmaceutical Industry

24 Jul 2008 07:58 GMT

... highly dynamic segment of the pharmaceutical and biotechnology industry," notes Frost & Sullivan Industry Analyst ... 2832 4713 niyer@frost.com or Corporate Communications - China: Amelia Wong, +86 21 5407 5783, ext. ...

Don't Be Worried About Losing Trades

24 Jul 2008 06:55 GMT

... the pattern and price action in iShares Hong Kong (EWH), which we bought on July 22. ... sectors in the domestic markets, the various biotech ETFs are still showing the most relative ...

Paul Capital Partners Promotes Ken Macleod To Partner

24 Jul 2008 06:37 GMT

... strong operational background in the pharmaceutical and biotechnology industries, where he previously held senior management ... of funds. The firm has offices in Hong Kong, London, New York, Paris, San Francisco, Sao ...

Syngenta Half Year Results 2008: Strong performance, positive outlook

24 Jul 2008 05:29 GMT

... herbicides. Emerging markets in Asia Pacific, notably China and India, continued to drive growth, more ... will capture a wide range of future biotech opportunities. The development of a fully traited ... new biotech research and technology center in Beijing for the early evaluation of GM and ...

Sigma-Aldrich (Nasdaq: SIAL) Reports 16.7% Gain in Q2 2008...

24 Jul 2008 04:34 GMT

... excess of long-term growth targets, and Research Biotech exceeded current year growth expectations, all after ... primary focus markets of India, Brazil and China ranged from 10% to 45% as we ...

VC director outlines global trends

24 Jul 2008 03:30 GMT

... By Dimitri Bruyas, The China Post news staff Thursday, July 24, 2008 ... cell therapy, as the main trends for biotech products worldwide, including in Israel. With the ... manages four funds totaling US$500 million. Given Taiwan's strong Information Technology (IT) sector, she suggested ...

BioBusiness forum assesses prospects of global value chain

24 Jul 2008 03:30 GMT

... global value chain By Dimitri Bruyas, The China Post news staff Thursday, July 24, 2008

Science Fiction Gets the Vapors

23 Jul 2008 23:17 GMT

... fingers stroke the sides of a tomato genetically modified with the DNA of distant jellyfish; their ... of books like Jay Lake's Mainspring and China Miville's Perdido Street Station and that recent ...

Just Group (JST) $3.29

23 Jul 2008 20:35 GMT

... Oh dear: Criterion's buy call on the biotech giant at $36.70 on Tuesday proved poorly ... Ramu cobalt and nickel project yesterday won Chinese funding to the tune of $US1.37 billion. China's Metallurgical Construction Corp (MCC), Ramu's 85 per ...

Agro-biotech start-up Kiima raises $8m

23 Jul 2008 17:32 GMT

... a method to increase crop yields. Israeli agro-biotech start-up Kiima has raised $8 million in ... "We now have a commitment from the Chinese government to set up a joint company ... in the Anhui Province in South East China, which has 10 million dunams of rapeseed, ...

BUYINS.NET: AGO, KNX, RYL, SOL, YZC, ARQL Have Been Added To Naked Short List Today

23 Jul 2008 17:28 GMT

... related products in the People's Republic of China. It offers silicon ingots and solar wafers, ... 2007. ArQule Inc. (NASDAQ: ARQL) a clinical-stage biotechnology company, engages in the research and development ...

Arbuckle farmers find green in purple asparagus

23 Jul 2008 17:20 GMT

... Plant Genetics, which created the "Flavor Saver" GMO tomato, and the couple moved to Arbuckle ... affordable labor, like Mexico, Peru, Chile and China. This has been a slow shift over ...

Genelabs inks hepatitis research deal with Taiwan

23 Jul 2008 16:51 GMT

... will work together with a private Taiwanese biotech and a nonprofit set up by the ... Genelabs (NASDAQ: GNLB) with the Republic of China's National Health Research Institutes and the private ...

PPD shares fall as 2Q bookings data disappoints

23 Jul 2008 16:33 GMT

... when clinical research organizations are seeing a boom in business from big pharma and biotech outsourcing and emerging markets like China and India. Wall Street has kept a mainly positive view on PPD and its ...

Genelabs partners with NHRI and Genovate for HCV program

23 Jul 2008 16:33 GMT

... Health Research Institutes, a non-profit foundation established by the government of the Republic of China, and Genovate Biotechnology, a fully integrated biopharmaceutical company in Taiwan. The intent of the collaboration between the three parties is to jointly conduct further ...